LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Novavax Inc

Chiusa

SettoreSettore sanitario

7.45 6.43

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

6.98

Massimo

7.47

Metriche Chiave

By Trading Economics

Entrata

600M

519M

Vendite

578M

667M

P/E

Media del settore

2.571

51.198

EPS

2.93

Margine di Profitto

77.798

Dipendenti

952

EBITDA

569M

516M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+60.94% upside

Dividendi

By Dow Jones

Utili prossimi

7 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

130M

1.1B

Apertura precedente

1.02

Chiusura precedente

7.45

Notizie sul Sentiment di mercato

By Acuity

50%

50%

166 / 380 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

Novavax Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 apr 2025, 17:06 UTC

I principali Market Mover

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31 mar 2025, 14:19 UTC

I principali Market Mover

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 feb 2025, 18:52 UTC

I principali Market Mover

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11 nov 2024, 14:05 UTC

I principali Market Mover

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16 ott 2024, 12:59 UTC

I principali Market Mover

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

19 mag 2025, 14:30 UTC

Notizie principali

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

19 mag 2025, 13:27 UTC

Notizie principali

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

8 mag 2025, 17:55 UTC

Utili

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

8 mag 2025, 15:12 UTC

Utili

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

28 apr 2025, 17:04 UTC

Utili

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

30 dic 2024, 23:02 UTC

Acquisizioni, Fusioni, Takeovers

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4 dic 2024, 07:09 UTC

Acquisizioni, Fusioni, Takeovers

Novavax: Agreement to Close by Dec 30 >NVAX

4 dic 2024, 07:08 UTC

Acquisizioni, Fusioni, Takeovers

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4 dic 2024, 07:07 UTC

Acquisizioni, Fusioni, Takeovers

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4 dic 2024, 07:06 UTC

Acquisizioni, Fusioni, Takeovers

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4 dic 2024, 07:06 UTC

Acquisizioni, Fusioni, Takeovers

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4 dic 2024, 07:04 UTC

Acquisizioni, Fusioni, Takeovers

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15 nov 2024, 13:34 UTC

Notizie principali

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 nov 2024, 11:14 UTC

Discorsi di Mercato

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16 ott 2024, 15:22 UTC

Utili

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

Confronto tra pari

Modifica del prezzo

Novavax Inc Previsione

Obiettivo di Prezzo

By TipRanks

60.94% in crescita

Previsioni per 12 mesi

Media 11.25 USD  60.94%

Alto 19 USD

Basso 7 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Novavax Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

4 ratings

1

Acquista

2

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

5.692 / 6.039Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Weak Bearish Evidence

Sentiment

By Acuity

166 / 380 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.